|
|
Volumn 23, Issue 9, 1998, Pages 970-976
|
|
Palivizumab. Antiviral
a
a
PROUS SCIENCE
(Spain)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AH 758;
ANTIVIRUS AGENT;
CL 387626;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
RD3 0028;
RIBAVIRIN;
UNCLASSIFIED DRUG;
VIRUS GLYCOPROTEIN;
ANTIVIRAL ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
IMMUNOGENICITY;
LIVER TOXICITY;
LUNG DYSPLASIA;
NEPHROTOXICITY;
NONHUMAN;
PREMATURITY;
RECOMBINANT DNA TECHNOLOGY;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
RESPIRATORY TRACT INFECTION;
VIRUS INFECTION;
VIRUS REPLICATION;
|
|
EID: 0032449042
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1998.023.09.470301 Document Type: Article |
|
Times cited : (1)
|
|
References (49)
|
